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Abstract
We describe and discuss the rationale, design and current implementation of a model for
an integrated intervention for the primary and secondary prevention of Zika and other
Aedes-borne diseases and sexually transmitted infections that impact reproductive
health, pregnancy and perinatal life stages in women and their families in Merida,
Mexico. The intervention includes enhanced surveillance of pregnant women, imple-
mentation of communication strategies to promote good practices to prevent disease
transmission, determination of the frequency of structural anomalies detected prenatally
in the foetus, umbilical cord and placenta of pregnancies diagnosed with ZIK infection,
detection of ZIKV and other arboviruses/viruses in products of abortion, in-utero and
early newborn, provision of Aedes aegypti-proof houses” (protecting homes with door/
window screens with insecticide to prevent the access of mosquitoes), mosquito repellents,
larvicides and education/promotion of best practices for the prevention of infection with
dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) and an anthropological studies
on sociocultural factors of pregnant women associated with ZIKV. This intervention is
being developed in a population of 10,000 people of the city of Merida and with the
participation of a multidisciplinary group of public health professionals in collaboration
with the Ministry of Health and the Government of Yucatan.
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1. Introduction
Dengue (DEN), chikungunya (CHIK) and now Zika (ZIKV) are Aedes-borne diseases (ABD) in
different transmission stages in southern Mexico, that is, endemic (DEN), epidemic (CHIK) and
emergent (ZIKV), that account for increasing number of cases, chronic disability conditions and
deaths along with the threat of increasing numbers of congenital disorders. While ABD face the
operational problems associated to the control the mosquito vector Aedes aegypti, ZIKV infection
has also a non-vectorial transmission route: vertical (transplacental and birth), sexual and/or by
blood transfusion which may compromise the health of the mother, fetus and the newborn [1].
The first outbreak of ZIKV outside of Africa and Asia was in Micronesia and affected 72% of
the population in 2007 [2] and was confirmed by Centers for Disease Control and Prevention
(CDC) [2, 3]. Transmission of (ZIKV) spread to Malaysia, the Philippines and French Polynesia.
In 2013–2014, French Polynesia reported a ZIKV outbreak reaching 60% of the popu-lation
[2–5]. In 2015, Brazil had an outbreak of ZIKV with 134,057 confirmed cases, were fatal and
80% were asymptomatic [6]. Colombia reported more than 65,000 positive cases of ZIKV
during the first half of 2016 [7]. The outbreak of ZIKV in Mexico started at the end of 2015 in
Chiapas where 8842 confirmed cases were reported by June of 2017. The Yucatan state, also in
south Mexico, has reported 1295 cases and most of confirmed Zika infections in pregnant
women (921 confirmed cases) in Mexico [6, 8, 9].
Recent ZIKV epidemiological alerts associate ZIKV/pregnancy with fetal/neonatal morbidity
and mortality because there was a marked increase in newborns that developed microcephaly
during the ZIKV outbreak in Brazil. By the end of 2015, detection by RNA sequencing of ZIKV
from amniotic fluid of foetuses with disorders in the central nervous system was the key for
the World Health Organization (WHO) to declare the ZIKVa public health emergency [10–12].
Actually, congenital Zika syndrome (CZS) involves craniofacial malformations (microcephaly,
craniofacial anomalies and facial dysmorphism), foetal brain disruption sequence and neural
tube defects [13–16]. DEN and CHIK as well, are associated with spontaneous abortion,
prematurity and congenital diseases, and the newborn may present thrombocytopenia, hepa-
tomegaly and develop neurological disorders.
The virus has been documented in body fluids as blood, tears, breast milk, vaginal discharge,
semen and tissues from abortions and stillbirths [17, 18]. Confirmation of infectious diseases
through laboratory diagnostic tests are often necessary; the arrival of ZIKV infection made that
the tools developed for other flaviviruses such as DEN, based on immune response (IgM, IgG),
would generate false positives to ZIKV. There are several working groups that are developing
more specific and sensitive IgM and IgG tests, so it is essential to be definite of the final
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diagnosis, due to the possible consequences that could involve a false positive or false negative
diagnosis. The polymerase chain reaction (PCR) has become the main mechanism for the diag-
nosis of ZIKV nuclei acid; however, compared to the viral particles of DEN and CHIK, the viral
particles of ZIKV are low and therefore the period to give a positive diagnosis in serum is very
short and challenging. Other possibilities are detection in urine saliva, breast milk and semen, in
pregnant women and their spouses, where a longer viremia is reported [17–20].
This situation challenges vector control and the surveillance system, the prevention of trans-
mission and the organization of health care systems that should effectively deal with the
concurrence of three diseases with different clinical outcomes and a common vehicle of
transmission. Major challenges include the establishment of a comprehensive communica-
tion strategy to sensitize and provide information regarding the risk of ZIKV infection in
pregnant women, and the early detection and confirmation of arboviral diseases in the target
group (pregnant women) in order to launch the preventive and control interventions. Addi-
tional challenges include the improvement or prenatal, pregnancy and newborn care in
primary health care centers and hospitals as well as strengthening the surveillance of ABD
in these areas.
We need to implement integrated strategies that can improve detection of infection and special
medical care for infected women, the follow-up of newborn at risk and the best preventive and
vector control measures. Herein, we describe and discuss the design and current implementa-
tion of an integrated model for primary and secondary preventive interventions for ZIKV,
along with other ABD and sexually transmitted infections, that impact reproductive health,
pregnancy and perinatal life stages in women and their upspring in Merida, Mexico.
We describe the rationale, components, implementation and evaluation of this intervention,
which includes:
• Enhanced surveillance of pregnant women, including the early detection of infectious
diseases such as syphilis, HIV and DEN/CHIK/ZIKV.
• Implementation of communication strategies, that is, prevention and control measures
against the bite of the mosquito vectors, family-planning strategies.
• Determination of the frequency of structural anomalies detected prenatally in the fetus,
umbilical cord and the placenta of pregnancies affected by infection with ZIKV.
• Detection of ZIKV, and other arboviruses/viruses in products of abortion, in-utero and
early newborn.
• Implementation of the strategy “Casas a prueba de Aedes aegypti/Aedes aegypti-proof
houses” in Yucatan (protecting homes and families with door/window screening to prevent
the access of mosquitoes), provision of mosquito repellents and larvicides, and education/
promotion of best practices for the prevention of infection with DEN, CHIK and ZIKV.
• Conducting an anthropological research of sociocultural factors associated with Zika virus.
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2. Enhanced surveillance of pregnant women, including the early detection
of infectious diseases such as syphilis, HIVand DEN/CHIK/ZIKV
In Merida, a strong collaborative work with local authorities is already in place with interven-
tions targeting high-risk areas and vulnerable populations. These efforts were initially orga-
nized for DEN control due to its endemic transmission in the area. Due to the introduction of
CHIK in early 2014, and the most recent introduction of ZIKV, the program has extended to
address these three ABD with major emphasis in ZIKV infection due to its high impact in the
newborn. “Familias sin Dengue project” (Figure 1) (financed by SANOFI-Pasteur) has
established a platform for the surveillance ad early detection of dengue infection that will be
used to improve detection of ZIKV infection in target women.
2.1. Surveillance of ZIKVand urban Aedes-borne diseases (ABD) with in the cohort study
“Familias sin dengue”
For Merida, the team has access to datasets containing the residential address of ~25,000 DEN
and ~5000 CHIK cases reported during 2011–2016 including the study area. The Cohort study:
“Familias sin Dengue” also provides a group of women in reproductive age who will be follow
through house visits in order to detect suspicion of ZIKV infection.
ZIKV infection in the general population presents with a mild disease that remit in 3–7 days.
ABD are endemic in Yucatan, and congenital infections result from the transmission of
Figure 1. Identification logo of the project families without dengue.
Current Topics in Zika52
infection from the mother to the foetus during pregnancy. Therefore, in populations with an
epidemiological association of ZIKV, pregnant women should be intentionally evaluated for
ZIKV during the development of clinical manifestations similar to those described [11]. It is
essential to establish a correct diagnosis in the pregnant woman due to the poor information
generated on the transmission, pathophysiology and diagnosis of the impact that this infec-
tion has on the product of gestation [10, 21].
The virus in addition to being identified in saliva, blood, semen, urine, in breast milk, has also
been found, but it is not known, if breastfeeding can affect the baby. But if vertical transmission
has been demonstrated through amniocentesis, with confirmation the presence of ZIKV by
PCR and reported lesions vary according to the time of infection and time of pregnancy.
However, information about ZIKV infection proximate to the conception period is scarce.
Women who are positive should have a follow-up for the search for morphological abnormal-
ities in their products. Zika infection in the mother with transmission to the fetus, causing a
group of structural abnormalities of at least the central nervous system (CNS), which produces
a sequence of cerebral disruption and causes a functional disability secondary to damage, is
denominated congenital Zika syndrome (CZS) [13, 22–24].
Enhanced surveillance searches for prenatal and/or neonatal morphological abnormalities in
all products of pregnancies affected by ZIKV. This performed by perinatologists specialized in
fetal medicine and geneticists from the dysmorphological approach. A family history is made
of all the patients with the purpose of obtaining a history of genetic diseases or the use of
teratogens that may imply in the diagnosis of maternal-fetal health.
According to the guidelines established by the CDC, there is no optimal time to perform an
ultrasonographic screening to detect microcephaly. On a daily basis, ultrasound surveil-
lance to detect structural abnormalities in a pregnancy is performed among the 18–20 weeks
of gestation [25]. Ultrasonographic follow-up should be performed from the beginning of
the ZIK symptomatology in the mother with a monthly monitoring depending on the
prenatal manifestations found. The variables investigated are intrauterine growth, cephalic
perimeter, central nervous system abnormalities and other structural abnormalities as
well as the presence of intracerebral and/or placental calcifications and the amount of
amniotic fluid.
Upon ultrasonographic findings of malformations in the product, the patient will be informed,
who will decide whether or not to follow the pregnancy. In case of a request for the interruption
of the pregnancy the case will be evaluated by a Bioethics Committee to define the resolution.
Pregnancies with or without ZIKV infection that culminate in abortion or early foetal death,
with prior informed consent, will be performed a genetic clinical evaluation, with collection
of body images, and evisceration or autopsy will be performed, as the case may be, to
obtain brain tissue, hepatic, cardiac and renal, to perform histopathological study and RT-
PCR for ZIKV nuclei acid in frozen and fixed tissue. The mother will be informed of the
findings and genetic counseling on care and risk will be given to reduce birth defects
in subsequent pregnancies. To date, there is no contraindication to vaginal delivery and
breastfeeding.
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2.2. Studies for the core group
The core group of the study are the pregnant women of two interventions; the cohort study
(Figure 2): “families without dengue” (Figure 1) and “Aedes aegypti-proof houses” (Figure 3) in
which previous informed and signed consent, with clarity the commitments that the group of
professionals, as well as the participant and their family have.
When a pregnant woman, her partner and family enter the project, the following diagnostic
tests and complementary studies are carried out (Figure 4):
A. Molecular detection of ZIKV is performed with the use of the Trioplex Real time RT-PCR
Assay from the Centers for Disease Control and Prevention (CDC), for detection and
differentiation of RNA from DEN, CHIK and ZIKV in serum and urine, to all members
of the family.
B. Serum and urine studies with Trioplex RT-PCR monthly to the pregnant woman and her
partner throughout pregnancy.
C. HIV and VDRL (syphilis) tests on the pregnant woman and her partner.
D. TORCH (toxoplasma, rubeola, cytomegalovirus and herpes) to the pregnant.
Figure 2. Map of the study areas in Merida, Yucatan, Mexico. (A) Map of Mexico with the location of the city Merida; (B)
distribution of the participants of the cohort from the project families without dengue; (C) intervention area in the
neighborhood Juan Pablo II.
Current Topics in Zika54
E. Blood count, blood chemistry, general urine test and erythrocyte folate profile in the
pregnant woman.
F. Obstetric ultrasound (quarterly).
2.3. Positive cases for ZIKV
In case the participant or any member of the family has signs and symptoms compatible with
DEN/CHIK/ZIKV, and have positive test result of: diagnostic test Trioplex RT-PCR DEN, CHIK
and ZIKV and serological tests of NS1 and IgG for dengue, IgM DEN, CHIK and ZIKV [20].
Figure 3. Identification logo of the intervention ‘Aedes aegypti-proof houses’.
Figure 4. Carnet for pregnant women: (a) front cover with general information of the project and how to contact the team
including a free telephonic number to communicate in case of presenting symptoms compatible with DEN/ CHIK/ ZIKV
and (b) record for diagnostic tests and complementary studies that are recommended for pregnant women.
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At the moment that the pregnant woman presents a positive result to ZIKV by the Trioplex RT-
PCR assay for DEN, CHIK and ZIKV, she is informed of the diagnosis with counselling and
psychological support in case of requesting it and the following studies and assessments are
requested:
A. Liver function tests.
B. Structural ultrasound/obstetric ultrasound (monthly).
C. Genetic consultation.
D. Obstetric consultation.
E. Amniocentesis with karyotype and diagnostic test Trioplex RT-PCR assay for DEN, CHIK
and ZIKV, if required.
At the end of the pregnancy, vaginal, cesarean or abortion, biological samples will be collected
to perform Trioplex RT-PCR assay for DEN, CHIK, ZIKV and anatomopathology and speci-
alised studies (karyotype):
A. Maternal blood
B. Product blood
C. Amniotic fluid
D. Placenta
E. Abortion product
F. Cerebrospinal fluid
3. Implementation of communication strategies, that is, prevention and
control measures against the bite of the mosquito vectors, family-planning
strategies
3.1. Preventive kits
All pregnant women will be provided with an educational/preventive kit containing (Figure 5):
1. Proven repellent (DEET 30%) recommended by CENAPRECE (Ministry of Health) for
protection outside the home.
2. Organic and environmentally friendly larvicide recommendedbyCENAPRECE (SPINOSAD).
3. Educational brochure for the promotion of good practices to avoid the risk of mosquito
bites (including use of repellent) and for the elimination and control of Aedes breeding
grounds (including the use of larvicides).
4. Thermometer for fever monitoring.
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5. Personal symptom monitoring card compatible with ZIKV and Carnet for registration of
laboratory tests.
6. Condoms (for prevention of possible transmission by sexual practices).
7. Access to 01800 CERO ZIKA (01800 09452) for report in case the pregnant or someone in
your family presents symptoms of Zika: erythema, fever, conjunctivitis or joint pain.
To supplement these direct actions, text messages are periodically sent with information
relevant to the case and reinforce preventive measures and home visits in search of febrile
illnesses. Those women residing in the area where the “Aedes aegypti-proof houses” strategy
will be evaluated will also receive the installation of long-lasting insecticide nets permanently
installed in doors and windows in their homes (see more detail in the next section).
3.2. Educational intervention with women of reproductive age and their partners for the
prevention of vector-borne diseases and sexually transmitted infections
The strategy of educational intervention is performed in the form of workshops. A “a peda-
gogical strategy, apparently simple, that by a learning methodology by doing in group, allows
to build meaning to those” someone “who participate in it in order to learn and know”
something “, from the integral insertion in the process” [26].
It is directed to the pregnant women who participate in the project and the women who are at
reproductive age within the family nuclei. Workshops are also held with their partners so that
Figure 5. Prevention kits for pregnant women.
An Integrated Intervention Model for the Prevention of Zika and Other Aedes-Borne…
http://dx.doi.org/10.5772/intechopen.71504
57
they are also aware of the information and are involved in the corresponding care during
pregnancy. Basically, workshops deliver topics related to health, body, sexuality, pregnancy
and strategies for prevention of vector-borne diseases and sexually transmitted infections.
The themes and objectives of the workshop are:
Topic 1. Body, pregnancy and sexuality.
General objective: to recognize the characteristics of the male and female body that make
possible a pregnancy and the processes of a normal pregnancy, to identify the benefits of a
planned pregnancy, the repercussions of an unplanned pregnancy, the health risks during
pregnancy and to recognize the importance of prenatal care.
Topic 2. Aedes-borne diseases and the presence of ZIKV in pregnancy.
General objective: to provide information for the prevention of DEN, CHIK and ZIK, as well as
the impact of this during pregnancy, identify the mechanisms of transmission:
A. Symptoms and signs of dengue, chikungunya and Zika.
B. Identify the activities they do and can do at home and in the community to prevent
Aedes-borne diseases.
C. Impact of Zika infection on pregnancy. Congenital malformations.
D. Promotion of the use of condoms as a method of prevention of Zika.
E. Recognize the importance of preventing Zika during pregnancy.
F. Recognize Zika as a preventable disease and not as a determinant for the presence of
congenital malformations.
Topic 3. HIV/STIs prevention.
Course objective: identify the risks of STI contagion with an emphasis on HIV.
A. Myths and realities.
B. Describe themost frequent STIs:HIV, gonorrhea, syphilis, herpes, andhumanpapillomavirus.
C. Mention what are the risk practices and routes of HIV and STI transmission.
D. Describe clinical picture (differences between HIV/AIDS and STIs) and diagnostic
methods, treatment and prognosis.
E. Identify methods of prevention of STIs (male condom, female condom, and abstinence.
Topic 4. Protected sex.
Course objective: Provide information on the male and female condom, and promote its use.
A. Perception of risks of contracting STIs.
B. Myths and realities.
C. Knowledge and importance of protected sex.
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D. Promote the practice of sex protected in sexually active population.
E. Knowledge, characteristics and correct use of the male and female condom.
F. Explain the correct use of the female condom (steps for its use).
Topic 5. Self-care of health.
General objective: To reflect on the self-care practices of health, identifying the consequences,
and benefits of self-care.
4. Determination of the frequency of structural anomalies detected
prenatally in the foetus, umbilical cord, and the placenta of pregnancies
affected by infection with ZIKV
Gestation products that come to term should be evaluated for a possible congenital infection
by ZIKV. Serum, placenta tissue, and urine should be obtained. The search for ZIKV RNA,
immunoglobulin M and neutralizing ZIKVantibodies as well as neutralizing antibodies and M
immunoglobulins for DEN is indicated. Tissue collection should be done within the first 2 days
of life, if possible [11]. For this reason, all pregnancy products are evaluated by a group of
experts, including clinical geneticists and pathologists, and the tissues are collected and evalu-
ated within the first 12 hours of life. The tissues are sent to the pathology service for histopath-
ological evaluation of the placenta and the umbilical cord. Immunohistochemical staining is
performed in fixed tissue and ZIKV RNA is sought by RT-PCR in fixed and frozen tissue.
Clinical evaluation implies a dysmorphlogical approach and records gestational age, Apgar,
occipitofrontal perimeter, height and weight. Neurological, craniofacial features, cutaneous,
thoracic, and abdominal abnormalities are recorded. If a specific abnormality is observed, an
evaluation by the appropriate specialist is requested [14]. Complementary studies are carried
out such as transfontanellar ultrasound, auditory, and neonatal screening.
Long-term follow-up involves evaluation for 18 months and includes follow-up by geneticist,
pediatrician, pediatric ophthalmology, audiologyandpediatric neurology.Amedical record of occi-
pitofrontal circumference (OFC), growth,weight, height and neuromotor development is kept [16].
The possible clinical scenarios to evaluate are:
1. The patient who is observed without microcephaly or morphological alterations and has
normal neurological development being the mother of a child without or with infection by
ZIK and
2. Those that are observed with microcephaly, morphological alterations and / or alterations of
the neuromotor development being children of mothers without or with infection or ZIKV.
In the latter group, previously well-established genetic syndromes, added teratogenic causes
and/or complementary genetic studies would be ruled out according to the individual needs of
each one.
The information will be collected in a database to be able to determine the frequencies.
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Patients who undergo microcephaly and/or brain disruption sequence will be given skull CT
and brain MRI to define CNS damage and its relationship to congenital infection by ZIKV.
Other interventions will be required according to the needs of each individual [27]. Other
interventions will be required according to the needs of each individual, such as the evaluation
by a paediatric cardiologist in the assumption of a cardiac murmur or paediatric nephrologist
for renal morphological abnormalities that compromise the function.
5. Effective vector control interventions for integrated prevention/control
of Aedes-borne diseases (ABD) including DEN/CHIK/ZIKVand targeted
on vulnerable population (pregnant women)
As described previously, the project is working to ensure that vulnerable population (pregnant
women and their families) are provided with the best possible support and care, including the
access of the best supplies for vector control and the prevention of Aedes-borne diseases (ABD);
this is personal and family protection in addition to the traditional activities performed by the
local health programs. This was urged in the Zika strategic response framework and joint
operations plan emitted by WHO [28], commending a proactive special care for pregnant
women, such as giving adequate repellent lotion and treated mosquito nets.
5.1. How can pregnant women protect themselves from mosquito bites?
The best protection from ZIKV is preventing mosquito bites. As stated by the most important
agencies worldwide such as the World Health Organization [29], the CDC [30], and the
Ministry of Health in Mexico, this can be done effectively and individually (and at the family
level) by the integrated use of: insect repellents, the use of physical barriers such as screens on
doors and windows to prevent mosquito bites outside and inside home; in an integrated
manner with the elimination of mosquito breeding sites, the application of larvicides and
application of insecticides to kill adult mosquitoes to control vector populations in and around
homes [31].
5.2. The entomological tools and interventions selected
For an effective and integrated prevention/control of ABD in this project we have chosen: the
best repellent with diethyltoluamide (DEET) available in the local market, the intervention
called “Aedes aegypti-proof houses” (“Casas a prueba de Aedes aegypti” in Spanish) which
involves insecticide-treated house screening (ITS) with use long-lasting insecticidal nets (LLIN)
permanently fitted to windows and doors to exclude A. aegypti, from houses, and the provision
of an environmentally safe biorational larvicide.
5.3. Repellent
In order to select the best repellent for this project, we assessed the efficacy of commercial
repellents available in Yucatan against A. aegypti. First results were reported by Uc-Puc et al.
[32]. Protection time was determined based on WHO/CTD/WHOPES/IC and Mexican
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regulations (NOM-032-SSA2–2014) [32–34]. Two products, both with DEET (N,N-diethyl-3-
methylbenzamide) >25% met the recommended protection (≥6 hours). The best repellent was
“Stop fly bung” with DEET at 30%. Efficacy was directly proportional to the concentration of
DEET; botanicals repellents resulted no protective. Repellents with DEET provided more
protection against A. aegypti and botanical repellents, including impregnated wristbands pro-
vided no protection [33, 34].
5.4. Larvicide
The selection of the larvicide was supported by previous evaluations of its efficacy under labora-
tory and field conditions and in consistency with the list of available products recommended by
the Mexican Ministry of Health [35–38]. The product selected was the biorational and environ-
mentally friendly larvicide Natular® DT (Spinosad 7.48%; Clarke Mosquito Control, IL, USA;
WHOPES approved) which is available in the formulation of a tablet for containerized water.
This product and formulation is a highly effective larvicide againstA. aegyptiwith a residuality of
9 weeks in field studies. In addition is non-toxic to humans, and also an option for the manage-
ment of insecticide resistance for local A. aegypti populations.
5.5. Aedes aegypti-proof houses
The intervention called Aedes aegypti-proof houses (“Casas a prueba de Aedes aegypti”) involves
insecticide-treated house screening (ITS) with use long-lasting insecticidal nets (LLIN) perma-
nently fitted to windows and doors to exclude A. aegypti, vector of dengue, chikungunya and
Zika (Figure 6).
The selection of these interventions was based on previous studies of our group. Briefly, from
2009 to 2014, cluster randomized controlled trials were conducted in the Mexican cities of
Acapulco and Merida. Intervention clusters received Aedes aegypti-proof houses with ITS and
followed-up during 2 years. Overall, results showed significant and sustained reductions on
adult vector densities in houses in the treated clusters with ITS after 2 years: ca. 50% on the
presence (OR ≤ 0.62, P < 0.05) and abundance (IRR ≤ 0.58, P < 0.05) of indoor-resting adults. ITS
Figure 6. Aedes aegypti-proof houses.
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on doors and windows are ‘user-friendly’ tool, with high levels of acceptance, requiring little
additional work or behavioral change by householders. ITS is a housing improvement that
should be part of the current paradigms for urban vector-borne disease control [36].
As described in Che-Mendoza et al. [37] andManrique-Saide et al. [39], Duranet® screens (0.55%
w.w. alpha-cypermethrin-treated non-flammable polyethylene netting [145 denier; mesh1⁄4132
holes/sq. inch]; Clarke Mosquito Control, Roselle, IL, USA; WHOPES approved for LLIN use)
were mounted in aluminum frames custom-fitted to doors and windows of houses in collabora-
tion with a local small business [37, 40]. An average of two doors and five windows by house
were installed in each intervention cluster. During installation, at least one person in every
household received information from research staff about the proper use andmaintenance of ITS.
5.6. Government agency as key partner in the intervention
These tools and interventions have fully political support by the Government of the State of
Yucatán who also gave financial support. In Merida, a strong collaborative work with local
authorities is already on-going and with this information we are already starting interventions
(and will start others) targeting high-risk areas and vulnerable populations. The authorities of
Mexico are considering how to expand Aedes-proof housing to as many homes as possible,
probably as a targeted intervention for high-risk areas (hot-spots) of endemic localities.
6. Zika, culture and pregnancy: An anthropological overview
The particularity of Zika virus presents a ‘double identity’ because it belongs to mosquito
vector-borne diseases and sexually transmitted infections. The initial cultural meanings of
ZIKV produced in local population uncertainty, misinformation, social fears and rumours.
Even in social networks like Facebook or Twitter, there was an entanglement of discourses that
increased confusion about symptoms, treatments, and consequences of this new outbreak.
Currently, we have noticed that incommensurability continues at stake on the cultural dimen-
sion of this emergent disease. That’s the reason why an anthropological overview will help us
to a better understanding of the sociocultural determinants of ZIKV. The final purpose is to
address cultural barriers and social acceptance of an integrated prevention model that pursuit
improves population health in Yucatan.
6.1. Research process
Our group of anthropologists is currently conducting three studies as part of this integrated
prevention model. First one, there is a research focused on sociocultural factors that pregnant
women associated with Zika virus in Yucatan, Mexico. Ethnographic and in-deep interview
methods are used for the collection data. The guidelines of this study are: source of informa-
tion about ZIKV; the mechanisms associated with Zika infection; social perceptions of symp-
toms; cultural beliefs about microcephaly and Guillain-Barre Syndrome; risk perceptions on
Zika virus; and the prevention and control practices of this target population. Also, we make
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anthropological analysis on focus group and workshops activities developed by medical crew
with pregnant women.
Second, there is research which main goal is focused on human mobility and its relation with
DENV, CHIKV and ZIKV transmission in Yucatan. A former and pioneer study was deployed
in Iquitos, Peru since 2007 [40]. We adapted surveys applied there to Yucatecan context,
coordinated by Gonzalo Vazquez-Prokopec. There are two types of questionnaires: the retro-
spective movement survey and the prospective movement survey. The first one, will help to
identify the amount of time DEN/CHIK/ZIKV-infected person spends at home as well array
locations. The second one is for not infected individuals. In both cases, we want to know about
their routine movements and the time-spatial quantification of them.
Third, we are making a rapid assessment on social perception about insecticide-treated screen-
ing (Aedes aegypti-proof houses). Pregnant women and their families are the main target of this
study. The topics this survey are: acceptance of the intervention, installation process, family
perception on positive and negative impacts of this technological innovation, comfort and heat
perception, families’ opinion on scale-up this project.
Finally, we are conducting a sociological assessment on the integrative prevention model. We
seek to address what is the social perception of pregnant women about the intervention (enroll-
ment process, information of Zika and ABD prevention practices), and follow-up health care of
pregnancy). In addition, we are exploring with in-deep interviews vulnerability experiences that
pregnant women have lived during and after the emergence of Zika outbreak in Yucatan.
6.2. Anthropological contributions
We expect, that this three and incoming social studies, will provide cross-cultural perspectives
on entomological, medical, ecological and epidemiological approaches. The common goal to
achieve, as a multidisciplinary team, is to produce a very positive impact of named interven-
tions in collaboration with local communities and government institutions. Since anthropolog-
ical point of view, we are strengthening the integrated prevention model by studying how
human factor is interweaved in an eco-bio-social context.
7. Discussion and conclusions
Here we described and discussed the design and current implementation of an integrated
model for primary and secondary preventive interventions for ZIKV, along with other ABD
and sexually transmitted infections that impact reproductive health, pregnancy and perinatal
life stages in women and their upspring in Merida, Mexico.
This intervention is being developed in a population of 10,000 people of the city of Merida and
with the participation of a multidisciplinary group of public health professionals (epidemiolo-
gists, obstetricians, geneticists, virologists, immunologists, pathologists, entomologists, ecolo-
gists, sexologists and anthropologists), in collaboration with the Ministry of Health and the
Government of Yucatan.
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There is not a full understanding of the risk for pregnant women, and the teratogenicity of
prenatal infections with ZIKV has not been completely elucidated [7, 10, 11, 13–15]. It is urgent
that a protocol designed for surveillance of pregnant women in endemic and invasive zones of
A. aegypti allow collection of information about the effects of ZIK in pregnant women, and to
delineate the neonatal phenotype of congenital abnormalities of the fetus related with ZIK.
This protocol will allow the establishment strategies related to the prevention and control of
emerging infectious diseases for future use [41, 42].
The implementation of complementary, innovative (not included by the traditional vector con-
trol programs), feasible and locally adapted approaches to vector control to reduce the risk of
Zika and other ABD, through personal protection, environmental management and community-
based partnership models can improve the current strategies for ABD prevention and control.
The results from the surveillance in a vulnerable population, will enable at least four strategies: (1)
create a program focused on a rapid recognition of any clinical symptoms for ZIKV; (2) set up
rehabilitation programs for motor, hearing and visual disabilities in order to support
neurodevelopment and quality of life for patients; (3) determine the performance of current vector
control and (4) establish measures and protocols in accordance with each specific population to
ensure the best results in surveillance, prevention and control of vector-borne diseases in vulner-
able populations. Finally, this strategy will allow development of human resources in research,
including educational cooperation and special experience in handling patients affected by ZIKV.
Therefore, this proposal will have direct impact on social, educational, economic and environ-
mental aspects concerned with the general health of the population, the collaboration and
engagement with government institutions are key factors to accomplish common goals on
public health and preventive strategies against vector-borne diseases.
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